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Edited by Vladimir SkulachevAbstract The disialoganglioside GD3 plays a major role in
proliferation, diﬀerentiation, and apoptosis. It has been reported
that ganglioside GD3 can induce apoptosis through bcl-2
mediated mitochondrial pathway. However, the relationship
between ganglioside GD3 and B-cell/CLL lymphoma 2 (Bcl-2) is
not fully understood. In this study, we have demonstrated that
the downregulation of Bcl-2 by overexpression of CMP-
NeuAc:GM3 a-2,8-sialyltransferase (GD3 synthase) results in
an accelerated apoptosis in vascular endothelial cells (ECV304),
as evidenced by DNA fragmentation and caspase-3 activation. In
addition, phosphorylation of AKT and cyclic-AMP responsive
element binding protein (CREB) was reduced by GD3 synthase
overexpression. Moreover, the activation of CREB as a
transcriptional factor was also inhibited, as evidenced by
electrophoretic mobility shift assay. Therefore, we conclude that
GD3 synthase has an apoptotic eﬀect on ECV304 cells through
downregulation of Bcl-2 expression via dephosphorylation of
AKT and CREB.
 2004 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Endothelial cells (ECs) form the lining of blood vessels and
regulate vascular function and homeostasis [1]. A number of
studies have shown that apoptosis of EC is important in the
pathogenesis of cardiovascular diseases, including diabetic
microangiopathy, angiogenesis and atherosclerosis [2–5]. Two
major apoptosis pathways have been deﬁned in mammalian
cells, the death receptor pathway and the mitochondria path-
way [5]. The B-cell/CLL lymphoma 2 (Bcl-2) family proteins
consist of both anti-apoptotic and pro-apoptotic members that
regulate apoptosis, mainly by controlling the release of cyto-
chrome c from mitochondria [6]. These two groups of proteins
can form both homo- and heterodimers and neutralized each* Corresponding author. Fax: +82-54-770-2281.
E-mail address: chkimbio@dongguk.ac.kr (C.-H. Kim).
Abbreviations: GD3 synthase, CMP-NeuAc:GM3 a-2,8-sialyltransfer-
ase; CREB, cyclic-AMP responsive element binding protein; Bcl-2, B-
cell/CLL lymphoma 2; Bax, Bcl-2-associated X protein; TLC, thin
layer chromatography; RT-PCR, reverse transcription-polymerase
chain reaction; SDS–PAGE, sodium dodecyl sulfate–polyacrylamide
gel electrophoresis; EMSA, electrophoretic mobility shift assays
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dependently or in concert to regulate apoptosis [6]. Upregu-
lation of anti-apoptotic protein Bcl-2 expression has been
identiﬁed as a critical mechanism by which growth factors
promote cell survival in vascular EC [7,8]. On the other hand,
many apoptotic agents such as hypoxia, cytokines and oxi-
dized low density lipoprotein (LDL) were reported that they
lower the expression of Bcl-2 [9–11].
Gangliosides are complex glycosphingolipids containing si-
alic acid residues and the changes in composition of ganglio-
sides have been observed during cell proliferation, cell cycle
phase, brain development and diﬀerentiation [12]. Among these
gangliosides, the disialoganglioside GD3, which is weakly ex-
pressed in most normal tissues, but highly expressed during
development and in pathological conditions such as cancer,
neurodegenerative disorders and atherosclerosis, is responsible
for diverse events such as proliferation, diﬀerentiation, and
apoptosis [13]. Recently, it was reported that high concentra-
tions of GD3 induce apoptosis in aortic smooth muscle cells
through recruiting reactive oxygen species [14]. In addition,
ganglioside GD3 can induce apoptosis through mitochondrial
pathway [15,16] and the forced expression of Bcl-2 signiﬁcantly
prevents GD3-induced apoptosis [16,17]. But the molecular
mechanism of GD3-induced apoptosis is not fully elucidated.
On the basis of these ﬁndings reported, we hypothesized that
the endogeneously synthesized ganglioside GD3 might act as a
pro-apoptotic agent to vascular EC. In this study, therefore, we
have demonstrated that the downregulation of Bcl-2 by CMP-
NeuAc:GM3 a-2,8-sialyltransferase (GD3 synthase) results in
an accelerated apoptosis in vascular endothelial ECV304 cells.
In addition, AKT and cyclic-AMP responsive element binding
protein (CREB) signaling pathway was inactivated by GD3
synthase overexpression, as evidenced byWestern blot analysis.
Moreover, the activation of CREB as a transcription factor was
also inhibited by GD3 synthase, as evidenced by electropho-
retic mobility shift assays (EMSA). This constitutes the ﬁrst
report to demonstrate that GD3 synthase has an eﬀect on the
expression of an anti-apoptotic protein Bcl-2.2. Materials and methods
2.1. Cell culture
ECV304 cells, an immortalized human vascular EC line [18], were
obtained from American Type Culture Collection (Rockville, MD).
ECV304 cells were cultured in Dulbecco’s modiﬁed Eagle’s mediumblished by Elsevier B.V. All rights reserved.
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fetal bovine serum (FBS; Life Technologies, Inc., Gaithersburg, MD)
and 1% penicillin/streptomycin (Life Technologies, Inc.), and main-
tained at 37 C in an atmosphere of 5% CO2. For DNA fragmentation
assay, the cells were grown in DMEM containing 10% FBS to sub-
conﬂuent monolayers, washed twice with phosphate-buﬀered NaCl
solution (PBS), and incubated with serum-free DMEM for 48 h.
2.2. Expression plasmids
To construct the GD3 synthase expressing plasmid, a 1.1 kb DNA
fragment including the human GD3 synthase coding region was
ampliﬁed by PCR using primer oligonucleotides (sense 50-
CTAAGCTTATGAGCCCCTGCGGGCGGGCCCGGCGACAA-30
and antisense 50-ATCTCGAGTCCTAGGAAGTGGGCTGGAGT-
GAGGTATCTTC-30) and human fetal brain cDNA as a template.
The sense and antisense primers contain HindIII and XhoI restriction
sites (underlined), respectively. The fragment was puriﬁed from 1%
agarose gels using the Wizard SV Gel and PCR Clean-Up System
(Promega, Madison, WI, USA) and digested with the appropriate re-
striction enzyme, and ligated using T4 ligase (Takara Bio Inc., Shiga,
Japan) into pcDNA3 vector, to generate pcDNA-GD3. To identify the
constructed vector, restriction mapping and DNA sequencing were
carried out.
2.3. Cell transfection and generation of stably transfected cell clones
Transfection of ECV304 cells was performed by electroporation, as
previously described [19]. The pcDNA3 and pcDNA-GD3 plasmids
were dissolved in PBS at a concentration of 300 lg/ml. A 400-ll ali-
quot of the cell suspension (1 107 cells/ml) was then mixed with 100
ll of the DNA solution in a Gene Pulser Cuvette (0.4 cm2 electrode
gap; Bio-Rad, Richmond, CA) on ice. Electroporation was carried out
with a Bio-Rad Gene-pulser apparatus set to ﬁeld strength of 300 V/cm
(capacitance 500 lF, resistance 300 X). The pulse-treated cells were
kept on ice for 10 min and transferred to 60-mm Petri dishes con-
taining 37 C DMEM with 10% FBS and cultured for 48 h. After
incubation, the transfected cells were cultured in the presence of 1000
lg/ml G418 (Life Technologies, Inc.). After 21 days in the selective
medium, individual G418-resistant colonies were isolated. Three po-
sitive clones, which are highly expressing GD3 synthase as determined
by reverse transcription-polymerase chain reaction (RT-PCR), were
used in further study.
2.4. Assessment of intracellular GD3 levels
Assessment of intracellular GD3 levels was performed as described
previously [20]. Cultured cells were washed twice with ice-cold PBS and
cells were scraped from the dishes and homogenized. Gangliosides were
extracted according to the method of Svennerholm and Fredman [21]
and analyzed by high-performance thin layer chromatography
(HPTLC) using analytical precoated Silica gel 60 HPTLC plates
(Merck, Darmstadt, Germany). All plates were ﬁrst activated by heating
to 100 C for 30 min. Samples were spotted onto plates with a Hamilton
syringe in chloroform:methanol:0.25% KCl (5:4:1, v/v/v). Authentic
GD3 (Wako Chemical Co., Osaka, Japan) was used as standard. GD3
was immunodetected by using the 4F6 anti-GD3 monoclonal antibody
(1:100; CovalAb, Lyon, France). The plates were incubated for 1 h at
room temperature with the primary antibody, washed twice with PBS–
Tween 20, and then incubated for 45 min at room temperature with a
horseradish peroxidase-conjugated rabbit anti-mouse antibody (1:200;
Sigma, St. Louis, MO). The GD3 bands were identiﬁed by enhanced
chemiluminescence system (Amersham Biosciences, Piscataway, NJ).
The bands were scanned and quantiﬁed by densitometric analysis using
TotalLab software (BioSystematica, Devon, UK) of Frog Gel Image
Analysis System (CorebioSystem, Seoul, Korea). The results shown are
means of three independent experiments.
2.5. DNA fragmentation assay
Total DNA was extracted according to the method of Lee and
Shacter [22]. Brieﬂy, the cultured cells were harvested, washed with
PBS, and lysed in buﬀer containing 10 mM Tris–HCl (pH 7.8), 10 mM
EDTA, 0.5% Triton X-100, 200 lg/ml RNase, and 200 lg/ml pro-
teinase K. After DNA was precipitated with isopropanol, it was then
resuspended in a Tris–EDTA solution. Samples were resolved by
electrophoresis on 1.5% agarose gels and visualized by ethidium bro-
mide staining and UV transillumination. A 1-kb DNA ladder served as
a marker for estimating DNA fragment size.2.6. RT-PCR analysis
Total RNA was extracted from parent, pcDNA3-transfected and
pcDNA-GD3-transfected ECV304 cells, using an TRIzol reagent (In-
vitrogen). Then, 1 lg of RNA from each sample was reverse-tran-
scribed into cDNA, using a SuperscriptTM pre-ampliﬁcation system
(Invitrogen). The cDNA obtained was further ampliﬁed by PCR
with the following primers: GD3 synthase (460 bp), 50-TGTGGT-
CCAGAAAGACATTTGTGGA-30 (sense) and 50-TGGAGTGAGG-
TATCTTCACATGGGT-30 (antisense); Bcl-2 (369 bp), 50-GGAG-
GATTGTGGCCTTCTTTGAG-30 (sense) and 50-TATGCACCCAG-
AGTGATGCAGGC-30 (antisense); Bcl-2-associated X protein (Bax)
(260 bp), 50-TGAACTGGACAACAACATGGAGC-30 (sense) and
50-GGTCTTGGATCCAGACAAACAGC-30 (antisense); b-actin
(275 bp), 50-CAAGAGATGGCCACGGCTGCT-30 (sense) and 50-
TCCTTCTGCATCCTGTCGGCA-30 (antisense). The use of equal
amounts of mRNA in the RT-PCR assays was conﬁrmed by analyzing
the expression levels of b-actin. The PCR product of Bcl-2 was
quantitated by densitometric analysis.
2.7. Western blot analysis
The cultured cells were homogenized in a sample buﬀer containing
50 mM Tris–HCl (pH 8.0), 150 mM NaCl, 0.02% NaN3, 100 lg/ml
PMSF, 1 lg/ml aprotinin, and 1% Triton X-100. Protein concentra-
tions were measured using the Bio-Rad protein assay (Bio-Rad).
Twenty lg samples of total cell lysates were size fractionated by so-
dium dodecyl sulfate–polyacrylamide gel electrophoresis (SDS–PAGE)
and electrophoretically transferred to nitrocellulose membranes using
the Hoefer electrotransfer system (Amersham Biosciences). To detect
Bcl-2, Bax, caspase-3, p-AKT, AKT, p-ERK, ERK, p-p38, p38, p-
CREB, CREB and GAPDH proteins, the membranes were incubated
with the Bcl-2, Bax (Zymed, San Francisco, CA), caspase-3, p-AKT,
AKT, p-p38, p38 (Santa Cruz, Santa Cruz, CA), p-ERK, ERK (New
England Biolabs, Beverly, MA), p-CREB, CREB (Upstate Biotech-
nology, Lake Placid, NY) and GAPDH antibodies (Chemicon,
Temecula, CA). Detection was performed using a secondary horse-
radish peroxidase-linked anti-mouse and rabbit antibody, and an en-
hanced chemiluminescence system (Amersham Biosciences).
2.8. Electrophoretic mobility shift assays
Nuclear extracts from parent, pcDNA3-transfected and pcDNA-
GD3-transfected ECV304 cells were prepared as described previously
[28]. EMSA was performed using a gel shift assay system kit (Promega)
according to the manufacturer’s instructions. Brieﬂy, double-stranded
oligonucleotides containing the consensus sequence for CREB (50-
ACCGTGTGACGTTACGC-30) were end-labeled with [c-32P]ATP
using T4 polynucleotide kinase and used as probes for EMSA. Nuclear
extract proteins (2 lg) were preincubated with the gel shift binding
buﬀer (4% glycerol, 1 mM MgCl2, 0.5 mM EDTA, 0.5 mM dithio-
threitol, 50 mM NaCl, 10 mM Tris–HCl (pH 7.5), and 0.05 mg/ml
poly(dI–dC)) for 10 min and then incubated with the labeled probe for
20 min at room temperature. Each sample was electrophoresed in a 4%
non-denaturing polyacrylamide gel in 0.5TBE buﬀer at 250 V for 20
min. The gel was dried and subjected to autoradiography.3. Results
3.1. Expression of GD3 synthase in ECV304 cells
To investigate the role of GD3 synthase on human vascular
EC, pcDNA-GD3 expression vector harboring the human
GD3 synthase cDNA and pcDNA3 empty vector were
transfected into the ECV304 cells by electroporation. After
selection of the G418-resistant colonies, the expression of GD3
synthase mRNA was highly expressed in pcDNA-GD3-
transfected cells compared with that in the parent and
pcDNA3-transfected cells (Fig. 1A). In addition, in pcDNA-
GD3-transfected cells, the overexpression of ganglioside GD3
was also identiﬁed by TLC immunostaining with anti-GD3
antibodies (Fig. 1B). These results show that the enzymatically
active GD3 synthase is synthesized in the pcDNA-GD3-
transfected cells.
Fig. 1. Apoptosis of ECV304 cells induced by overexpression of GD3 synthase. (A) ECV304 cells were transfected with the pcDNA-GD3 expression
vector harboring the human GD3 synthase cDNA. After selection of the G418-resistant colonies, three transfectants (GD3#3, GD3#8 and GD3#12)
were compared to parent ECV304 cells (Con) and pcDNA3-transfected cells (pcDNA3) for GD3 synthase expression by RT-PCR analysis, using b-
actin as an internal control. (B) A representative TLC immunostained with anti-GD3 antibodies and densitometric analysis of three independent
experiments. Values are expressed as percentages of control and present means S.E. (C) After deprivation of serum for 48 h, nucleosomal DNA was
isolated and separated by electrophoresis on 1.5% agarose gels. The DNA was stained with ethidium bromide and visualized under UV light. Similar
patterns of gel electrophoresis were obtained in three separate experiments. (D) After deprivation of serum for 48 h, the activation of caspase-3 was
determined by Western blot analysis. Similar data were obtained in three independent experiments.
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The DNAs from parent, pcDNA3-transfected and pcDNA-
GD3-transfected cells, which were cultured in serum-free
condition for 48 h, were resolved by electrophoresis. As shown
in Fig. 1C, the agarose gel electrophoresis of DNA isolated
from the GD3 synthase overexpressing cells showed a ladder
of DNA fragment. In addition, overexpression of GD3 syn-
thase results in caspase-3 activation, as revealed by the detec-
tion of the caspase-3 p17 fragment (Fig. 1D). This indicates
that GD3 synthase induces the apoptosis of ECV304 cells.Fig. 2. Overexpression of GD3 synthase downregulated the expression of Bc
transfected (GD3#3, GD3#8 and GD3#12) cells (5 105 cells/ml) were cultu
of Bcl-2 and Bax were measured by RT-PCR with the total RNA isolated
tensities of Bcl-2 bands in three independent experiments were analyzed using
and present means S.E. (B) Each of the cell lysates with equal protein conte
using GAPDH as an internal control. The blots were scanned, and the intens
and expressed using the same methods as above.We next examined the molecular mechanisms of apoptosis
induced by GD3 synthase overexpression. Especially, we have
focused on the Bcl-2 and Bax proteins, which are main reg-
ulators in mitochondrial pathway of apoptosis [6]. Interest-
ingly, in pcDNA-GD3-transfected cells, Bcl-2 mRNA and
protein levels were signiﬁcantly decreased, as assayed by RT-
PCR and Western blot analysis, whereas no signiﬁcant
change was observed in Bax (Fig. 2). Thus, the ratio of Bcl-2
to Bax was signiﬁcantly decreased in GD3 synthase trans-
fected cells.l-2. Parent (Con), pcDNA3-transfected (pcDNA3) and pcDNA-GD3-
red for 24 h and washed twice with ice-cold PBS. (A) The mRNA levels
from each cell, using b-actin as an internal control. Densitometric in-
the TotalLab software. Values are expressed as percentages of control
nt (20 lg) were electrophoresed and immunoblotted for Bcl-2 and Bax
ities of Bcl-2 bands in three independent experiments were quantitated
Fig. 3. Overexpression of GD3 synthase inhibited the phosphorylation of AKT and CREB, and translocation of CREB into the nucleus. Parent
(Con), pcDNA3-transfected (pcDNA3) and pcDNA-GD3 transfected (GD3#3, GD3#8 and GD3#12) cells (5 105 cells/ml) were cultured for 24 h
and washed twice with ice-cold PBS. (A) The cell lysates containing equal protein content (20 lg) were separated by SDS–PAGE and analyzed by
Western blotting. (B) The nuclear extracts were incubated with 32P labeled probe, containing the consensus sequence for CREB from the region of
Bcl-2 promoter. The DNA-protein complexes were analyzed on a 4% non-denaturing polyacrylamide gel.
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synthase overexpression
To investigate molecular mechanism of Bcl-2 downregula-
tion, we have examined the activation of AKT, ERK, p38 and
CREB. As shown in Fig. 3A, the expression of AKT and
CREB in parent, pcDNA3-transfected and pcDNA-GD3-
transfected ECV304 cells was similar, but the phosphorylated
AKT and CREB were dramatically decreased in pcDNA-
GD3-transfected cells, as evidenced by Western blot analysis.
But the expression and activation of ERK and p38 have no
signiﬁcant changes.
To additionally conﬁrm that GD3 synthase overexpression
is involved in the CREB-mediated transcriptional activation of
Bcl-2, we examined the binding of CREB to oligonucleotides
that contain the sequence for the CRE binding site from the
Bcl-2 promoter by EMSA. As shown in Fig. 3B, the intensity
level of the shifted band in the nuclear lysates from pcDNA-
GD3-transfected cells was lower than those for the nuclear
lysates from parent and pcDNA3-transfected cells (Fig. 3B).
These results suggest that overexpression of GD3 synthase
regulates AKT/CREB-mediated transcription of Bcl-2 gene.4. Discussion
The disialoganglioside GD3 is synthesized by a-2,8-sialyl-
transferase, called the GD3 synthase (ST8Sia I or sialyltrans-
ferase II), which is a type II transmembrane protein of
approximately 40 kDa, through catalyzing the addition of a
second sialic acid residue to one of its immediate precursor
GM3 [24,25]. To examine the function of endogeneously syn-
thesized GD3 synthase in EC, we constructed GD3 synthase
expressing vector, pcDNA-GD3, and transfected the vector
into immortalized human umbilical vein EC line, ECV304 cells
[18]. The transfected cells highly expressed GD3 synthase and
consequently ganglioside GD3 (Fig. 1A and B).
It has been reported that the ganglioside GD3 is weakly
expressed in normal vascular tissues and vascular ECs [26,27].
But the expression of ganglioside GD3 is important in the
pathologic conditions, including angiogenesis, diabetic micro-
angiopathy and atherosclerosis [28–30]. Moreover, apoptosisof EC plays a key role in such diseases [2–4,31]. Recently, it
was reported that the ganglioside GD3 induces mitochondrial
damage and apoptosis [15,16]. Thus, we examined the apop-
totic eﬀect of endogeneously expressed ganglioside GD3 syn-
thase in ECV304 cells. The agarose gel electrophoresis of DNA
isolated from the cells overexpressing GD3 synthase showed a
ladder of DNA fragments (Fig. 1C). In addition, the activation
of caspase-3 was determined in the cells overexpressing GD3
synthase (Fig. 1D). This indicates that GD3 synthase induces
the apoptosis of ECV304 cells.
Three diﬀerent mechanisms that were involved in GD3-
induced apoptosis have been reported, i.e., direct targeting to
mitochondria in a Bcl-2-controlled manner [16], suppressing
the nuclear factor-jB-dependent survival pathway [32] and
recruiting reactive oxygen species [14]. In the regulatory
mechanism of EC apoptosis, Bcl-2 is a well-known inhibitor of
apoptosis by forming a dimer with the pro-apoptotic protein,
Bax [33]. In addition, several studies have reported that ex-
pression of Bcl-2 is suppressed in apoptosis of human vascular
ECs [9–11]. Moreover, it was reported that GD3-induced ap-
optosis was reversed by forced expression of Bcl-2 [15,16].
Therefore, we assumed that the downregulation of Bcl-2 ex-
pression might be related with the apoptosis of pcDNA-GD3-
transfected cells. As shown in Fig. 2, levels of Bcl-2 mRNA
and protein were signiﬁcantly decreased in pcDNA-GD3-
transfected cells compared with those of parent and pcDNA3-
transfected cells, whereas no signiﬁcant change was observed
in Bax. Thus, the ratio of Bcl-2 to Bax was signiﬁcantly de-
creased in GD3 synthase-transfected cells.
The Bcl-2 gene is transcriptionally regulated by many tran-
scription factors including CREB, p53, Wilms’ tumor-1 gene
and estrogen receptor [34–37]. However, the basal activity of
Bcl-2 mediated primarily by CREB [34,38] and CREB medi-
ates the induction of Bcl-2 by a number of growth factors
through a signaling pathway mediated by ERK, p38 and AKT
[23,39,40]. Therefore, we examined the AKT, ERK and p38
signal pathway. The results showed that the activation of AKT
and CREB was dramatically decreased in pcDNA-GD3-
transfected cells, whereas the activation of ERK and p38 has
no signiﬁcant change (Fig. 3A). In addition, binding activity of
CREB to the CRE site of Bcl-2 promoter was signiﬁcantly
Fig. 4. Schematic representation of ganglioside GD3-induced apop-
tosis in ECV304 cells. Ganglioside GD3, which is produced by over-
expressed GD3 synthase, may downregulate the expression of anti-
apoptotic protein, Bcl-2, through inhibition of AKT/CREB signal
pathway. The downregulation of Bcl-2, and consequent imbalance
between Bcl-2 and Bax can cause apoptosis in ECV304 cells.
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EMSA (Fig. 3B). These results suggest that endogeneously
expressed ganglioside GD3 downregulates AKT/CREB-medi-
ated transcription of Bcl-2 gene.
In conclusion, the overexpression of GD3 synthase down-
regulates the expression of anti-apoptotic protein, Bcl-2,
through inhibition of AKT and CREB signal pathway. The
downregulation of Bcl-2, and consequent imbalance between
Bcl-2 and Bax can cause apoptosis in ECV304 cells (Fig. 4).
Therefore, this is, to our best knowledge, the ﬁrst report to
demonstrate that endogeneously expressed ganglioside GD3
has an apoptotic eﬀect on ECV304 cells through downregu-
lation of Bcl-2 expression.Acknowledgements: This work was supported by National Research
Laboratory Program, KISTEP, MOST, Korea (No. M10203000024-
02J0000-01300 to C.-H. Kim).References
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